Edsun Duarte Moreira Junior; William Harrington Junior; Terezinha Tupinamhá Ribeiro; Ailton Melo; Carlos Brites; Roberto Badaró; Priscila Swanson; Helen Lee
Texto completo disponível apenas em PDF.
Full text available only in PDF format.
REFERÊNCIAS BIBLIOGRÁFICAS
1. Cortes E, Detels R, Aboulafia D, Li XL, Moudgil T, Alam M, Bonecker C, Gonzaga A, Oyafuso L, Tondo M, Boite C, Hammershlack N, Capitani C, Slamon DJ, Ho DD. HIV-1, HIV-2, and HTLV-I infection in high-risk groups in Brazil. New England Journal of Medicine 320:953-959, 1989. [ Links ]
2. Costa CMC, Salgueiro MR, Cartoon H, Vale OC, Arruda AM. Tropical spastic paraperesis in Northeastern Brazil. Arquivo de Neuropsiquiatria São Paulo 47:134-138, 1989. [ Links ]
3. Hunsmann G, Bayer H, Shneider J, Schimitz H, Kern P, Dietrich M, Blattner DW, Goudeau AM, Kulkarni G, Fleming AF. Antibodies to ATLV/ HTLV-I in Africa. Medical Microbiology Immunology 173:167-170, 1984. [ Links ]
4. Kalyanaraman VS, Samgadharan MG, Robert- GuroffM, Miyoshil, Blayney D, GoldD, Gallo RC. A new subtype of human T cell leukemia virus (HTLV-II associated with a T-cell variant of hairy cell leukemia. Science 218:571-573, 1982. [ Links ]
5. Pombo de Oliveira MS, Matutes E, Famadas LC, Schulz TF, Calabro ML, Nucci M, Andrada-Serpa MJ, Tedder RS, Weiss RA, Catovsky D. Adult T- cell leukaemia/lymphoma in Brazil and its relation to HTLV-I. Lancet 336:987-990, 1990. [ Links ]
6. Public Health Service Working Group (FDA/CDC/ NIH). Licensure of screening tests for antibody human T lymphotropic virus type I. Morbid Mortal Weekly Republic 37:736-747, 1988. [ Links ]
7. Robert-Gouroff M, Weiss SH, Giron JA, Jennings AM, Ginzburg HM, Margolis IB, Blattner WA, Gallo RC. Prevalence of antibodies to HTLV-I, -II and -III in intravenous drug abusers from an AIDS endemic region. Journal of the American Medical Association 225:3133-3137, 1986. [ Links ]
8. Teder RS, Shanson DC, Jeffries DJ, Cheingsong- Popov R, Clapham P, Dalgleish A, Nagy K, Weiss RA. Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphodenopathy, and at risk of AIDS. Lancet 11:125-128, 1984. [ Links ]
9. Weber J. HTLV-I infection in Britain. British Medicine of Journal 301:71-72, 1990. [ Links ]
10. Williams AE, Fang CT, Slamon D, Poiesz B, Sandler SG, Darr WF, Shulman G, McGowan EL, Douglas D, Bowman R, Peetom F, Kleinman S, Lenes B, Prince H, Dodd R. Seroprevalence and epidemiologic correlates of HTLV-I infection in US blood donors. Science 240:643-646, 1988. [ Links ]
11. Zack JA, Cann AJ, Lugo JP, Chen ISY. HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation. Science 240:1026-1029, 1988. [ Links ]
Endereço para correspondência:
Dr. Roberto Badaró
Laboratório de Retrovirus / HU Prof. Edgard Santos/ UFBA.
R João das Botas s/n, 6° andar.
40110-160
Salvador, BA.
Recebido para publicação em 27/01/92.
Laboratório de Retrovirus, Hospital Universitário Professor Edgard Santos. Universidade Federal da Bahia, Salvador BA, Brasil and University of Miami, Cornell University Medical College, New York, Abbott Laboratories, North Chicago, IL USA.
Supported by Grants AI 26506 and TW 0018 from the United Slates Public Health Service.
